Table 2 ARDS management and outcomes in 863 ARDS patients with and without cirrhosis
Characteristics | Total (%) (n = 863) | Patients with cirrhosis (n = 157) | Patients without cirrhosis (n = 706) | p value |
|---|---|---|---|---|
Prone positioning | 317 (37%) | 47 (30%) | 270 (38%) | 0.06 |
NMBA | 485 (56%) | 78 (50%) | 407 (58%) | 0.08 |
Inhaled nitric oxide | 81 (9%) | 7 (4%) | 74 (10%) | 0.03 |
Corticosteroids | 354 (41%) | 129 (83%) | 225 (32%) | < 0.001 |
ECMO | 18 (2%) | 2 (1%) | 16 (2%) | 0.43 |
Ventilator-associated pneumonia | 156 (18%) | 32 (20%) | 124 (18%) | 0.87 |
MV-free days at 28 day, mean (± SD) | 21 (± 7) | 22 (± 6) | 21 (± 7) | 0.18 |
ICU length of stay, mean (± SD) | 14 (± 13) | 15 (± 12) | 14 (± 13) | 0.07 |
Hospital length of stay, mean (± SD) | 23 (± 24) | 19 (± 23) | 24 (± 24) | 0.01 |
7 day mortality | 146 (17%) | 37 (24%) | 109 (15%) | 0.01 |
28 day mortality | 308 (36%) | 78 (50%) | 230 (33%) | < 0.001 |
90 day mortality | 378 (44%) | 90 (57%) | 288 (41%) | < 0.001 |